{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:27:02Z","timestamp":1790616422944,"version":"4.1.0"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2013,10,21]],"date-time":"2013-10-21T00:00:00Z","timestamp":1382313600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0078330","type":"journal-article","created":{"date-parts":[[2014,4,30]],"date-time":"2014-04-30T20:42:55Z","timestamp":1398890575000},"page":"e78330","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":77,"title":["Sitagliptin Reduces Cardiac Apoptosis, Hypertrophy and Fibrosis Primarily by Insulin-Dependent Mechanisms in Experimental type-II Diabetes. Potential Roles of GLP-1 Isoforms"],"prefix":"10.1371","volume":"8","author":[{"given":"Bel\u00e9n","family":"Picatoste","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Caro-Vadillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Iborra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Egido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Tu\u00f1\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d3scar","family":"Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,10,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc09-S013","article-title":"Standards of medical care in diabetes","volume":"32","year":"2009","journal-title":"Diabetes Care"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.amjmed.2008.03.046","article-title":"Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options","volume":"121","author":"A Aneja","year":"2008","journal-title":"Am J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1006\/jmcc.2000.1197","article-title":"Diabetes-induced myocardial structural changes: role of endothelin-1 and its receptors","volume":"32","author":"S Chen","year":"2000","journal-title":"J Mol Cell Cardiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1161\/01.CIR.101.8.899","article-title":"Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model","volume":"101","author":"K Mizushige","year":"2000","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2337\/dc07-0228","article-title":"Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: preclinical biology and mechanisms of action","volume":"30","author":"DJ Drucker","year":"2007","journal-title":"Diabetes Care"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/01.CIR.0000120505.91348.58","article-title":"Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion","volume":"109","author":"LA Nikolaidis","year":"2004","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.cardfail.2006.08.211","article-title":"Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure","volume":"12","author":"GG Sokos","year":"2006","journal-title":"J Card Fail"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1161\/CIRCULATIONAHA.107.739938","article-title":"Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways","volume":"117","author":"K Ban","year":"2008","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s00125-012-2561-x","article-title":"The incretin hormones: from scientific discovery to practical therapeutics","volume":"55","author":"S Mudaliar","year":"2012","journal-title":"Diabetologia"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/MPA.0b013e3181bc30dd","article-title":"Glucagon like peptide-1-directed human embryonic stem cells differentiation into insulin-producing cells via hedgehog, cAMP, and PI3K pathways","volume":"39","author":"H Hui","year":"2010","journal-title":"Pancreas"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2199-8-54","article-title":"Transcriptional response of pancreatic beta cells to metabolic stimulation: large scale identification of immediate-early and secondary response genes","volume":"8","author":"DA Glauser","year":"2007","journal-title":"BMC Mol Biol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.pharmthera.2009.12.001","article-title":"Peroxisome proliferator-activated receptor beta\/delta (PPARbeta\/delta) acts as regulator of metabolism linked to multiple cellular functions","volume":"125","author":"K-D Wagner","year":"2010","journal-title":"Pharmacol Ther"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.abb.2007.01.028","article-title":"PPARbeta\/delta activation inhibits angiotensin II-induced collagen type I expression in rat cardiac fibroblasts","volume":"460","author":"H Zhang","year":"2007","journal-title":"Arch Biochem Biophys"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1463-1326.2007.00787.x","article-title":"Islet gene expression and function in type 2 diabetes; studies in the Goto-Kakizaki rat and humans","volume":"9","author":"C-G Ostenson","year":"2007","journal-title":"Diabetes Obes Metab"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S1734-1140(09)70147-1","article-title":"Antihyperglycemic effects of ASP8497 in streptozotocin-nicotinamide induced diabetic rats: comparison with other dipeptidyl peptidase-IV inhibitors","volume":"61","author":"A Tahara","year":"2009","journal-title":"Pharmacol Rep"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/00365518709168885","article-title":"Radio-immunoassays for glucagon-like peptides 1 and 2 (GLP-1 and GLP-2)","volume":"47","author":"C Orskov","year":"1987","journal-title":"Scand J Clin Lab Invest"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.euje.2003.11.004","article-title":"Echocardiographic assessment of left ventricular midwall mechanics in spontaneously hypertensive rats","volume":"5","author":"EM Escudero","year":"2004","journal-title":"Eur J Echocardiogr"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"H1361","DOI":"10.1152\/ajpheart.00885.2010","article-title":"Antiapoptotic effects of GLP-1 in murine HL-1 cardiomyocytes","volume":"300","author":"S Ravassa","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1073\/pnas.95.6.2979","article-title":"HL-1 cells: A cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte","volume":"95","author":"WC Claycomb","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e41545","DOI":"10.1371\/journal.pone.0041545","article-title":"DIOL triterpenes block profibrotic effects of angiotensin II and protect from cardiac hypertrophy","volume":"7","author":"R Mart\u00edn","year":"2012","journal-title":"PLOS ONE"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1083\/jcb.130.2.393","article-title":"Identification and characterization of a fibroblast marker: FSP1","volume":"130","author":"F Strutz","year":"1995","journal-title":"J Cell Biol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"H656","DOI":"10.1152\/ajpheart.00726.2001","article-title":"Palmitate-induced apoptosis in neonatal cardiomyocytes is not dependent on the generation of ROS","volume":"282","author":"DLM Hickson-Bick","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1055\/s-0031-1284383","article-title":"Sitagliptin augments protective effects of GLP-1 against advanced glycation end product receptor axis in endothelial cells","volume":"43","author":"Y Ishibashi","year":"2011","journal-title":"Horm Metab Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.jprot.2011.12.023","article-title":"Proteome changes in the myocardium of experimental chronic diabetes and hypertension: Role of PPAR\u03b1 in the associated hypertrophy","volume":"75","author":"S Ares-Carrasco","year":"2012","journal-title":"J Proteomics"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2165\/11203790-000000000-00000","article-title":"Sitagliptin: a review of its use in the management of type 2 diabetes mellitus","volume":"70","author":"S Dhillon","year":"2010","journal-title":"Drugs"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"11880","DOI":"10.1016\/S0021-9258(18)67324-7","article-title":"Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing","volume":"261","author":"S Mojsov","year":"1986","journal-title":"J Biol Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"H1454","DOI":"10.1152\/ajpheart.00867.2009","article-title":"The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA","volume":"298","author":"Y Ye","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1463-1326.2010.01345.x","article-title":"Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control","volume":"13","author":"P Anagnostis","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2337\/db08-1193","article-title":"GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice","volume":"58","author":"MH Noyan-Ashraf","year":"2009","journal-title":"Diabetes"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00395-013-0329-1","article-title":"Impaired mitochondrial biogenesis due to dysfunctional adiponectin-AMPK-PGC-1\u03b1 signaling contributing to increased vulnerability in diabetic heart","volume":"108","author":"W Yan","year":"2013","journal-title":"Basic Res Cardiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.jacc.2010.07.033","article-title":"Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy","volume":"56","author":"M Rajesh","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"H2109","DOI":"10.1152\/ajpheart.00157.2009","article-title":"Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes","volume":"297","author":"S Ares-Carrasco","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1113\/expphysiol.2011.058271","article-title":"Left Ventricle Structural Remodelling in the Prediabetic Goto-Kakizaki Rat","volume":"96","author":"A D\u2019Souza","year":"2011","journal-title":"Exp Physiol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/01.CIR.102.4.470","article-title":"Left ventricular hypertrophy: pathogenesis, detection, and prognosis","volume":"102","author":"BH Lorell","year":"2000","journal-title":"Circulation"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1146\/annurev.me.34.020183.001113","article-title":"Congestive heart failure in the diabetic","volume":"34","author":"TJ Regan","year":"1983","journal-title":"Annu Rev Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.yjmcc.2011.08.001","article-title":"Effects of DPP-4 inhibition on cardiac metabolism and function in mice","volume":"51","author":"M Lenski","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1517\/14656566.2012.656088","article-title":"Alogliptin benzoate for the treatment of type 2 diabetes","volume":"13","author":"M Rendell","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1463-1326.2008.00876.x","article-title":"Glucose-lowering activity of the dipeptidyl peptidase-4 inhibitor saxagliptin in drug-naive patients with type 2 diabetes","volume":"10","author":"J Rosenstock","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/MOL.0b013e32834622a2","article-title":"Enteroendocrine cells and lipid absorption","volume":"22","author":"G Mellitzer","year":"2011","journal-title":"Curr Opin Lipidol"},{"key":"ref40","doi-asserted-by":"crossref","DOI":"10.1186\/1758-5996-4-8","article-title":"Differentiating among incretin-based therapies in the management of patients with type 2 diabetes mellitus","author":"M Cobble","year":"2012"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2337\/db09-0955","article-title":"Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice","volume":"59","author":"M Sauv\u00e9","year":"2010","journal-title":"Diabetes"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.mvr.2012.06.008","article-title":"Glucagon-like peptide-1 inhibits angiotensin II-induced mesangial cell damage via protein kinase A","volume":"84","author":"Y Ishibashi","year":"2012","journal-title":"Microvasc Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.2337\/db11-1824","article-title":"Protective effects of GLP-1 on glomerular endothelium and its inhibition by PKC\u03b2 activation in diabetes","volume":"61","author":"A Mima","year":"2012","journal-title":"Diabetes"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.109.899377","article-title":"DPP-4 inhibition by sitagliptin improves the myocardial response to dobutamine stress and mitigates stunning in a pilot study of patients with coronary artery disease","volume":"3","author":"PA Read","year":"2010","journal-title":"Circ Cardiovasc Imaging"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1210\/en.2003-0007","article-title":"Cardiac function in mice lacking the glucagon-like peptide-1 receptor","volume":"144","author":"R Gros","year":"2003","journal-title":"Endocrinology"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tem.2009.11.007","article-title":"Insulin-like actions of glucagon-like peptide-1: a dual receptor hypothesis","volume":"21","author":"E Tomas","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"ref47","first-page":"1876","article-title":"Beneficial effects of metformin on primary cardiomyocytes via activation of adenosine monophosphate-activated protein kinase","volume":"124","author":"X-F Wang","year":"2011","journal-title":"Chin Med J (Engl)"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/cvr\/cvq066","article-title":"Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1-Smad3 signalling pathway","volume":"87","author":"H Xiao","year":"2010","journal-title":"Cardiovasc Res"},{"key":"ref49","article-title":"The Cardiovascular Effects of GLP-1 Receptor Agonists. Cardiovasc Ther","author":"T Okerson","year":"2010"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/ATVBAHA.110.206425","article-title":"Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A","volume":"30","author":"H Oeseburg","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.bbalip.2007.04.018","article-title":"Modulation of PPAR activity via phosphorylation","volume":"1771","author":"KA Burns","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/cvr\/cvp106","article-title":"Peroxisome proliferator-activated receptor beta stimulation induces rapid cardiac growth and angiogenesis via direct activation of calcineurin","volume":"83","author":"N Wagner","year":"2009","journal-title":"Cardiovasc Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1055\/s-0030-1253373","article-title":"The decreased expression of peroxisome proliferator-activated receptors delta (PPARdelta) is reversed by digoxin in the heart of diabetic rats","volume":"42","author":"SC Fan","year":"2010","journal-title":"Horm Metab Res"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/CIRCRESAHA.108.189159","article-title":"Peroxisome proliferator-activated receptor {delta} regulates extracellular matrix and apoptosis of vascular smooth muscle cells through the activation of transforming growth factor-{beta}1\/Smad3","volume":"105","author":"HJ Kim","year":"2009","journal-title":"Circ Res"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.bbrc.2007.08.115","article-title":"Reversal of islet GIP receptor down-regulation and resistance to GIP by reducing hyperglycemia in the Zucker rat","volume":"362","author":"S Piteau","year":"2007","journal-title":"Biochem Biophys Res Commun"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0091601","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T00:00:00Z","timestamp":1393545600000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0078330","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T16:29:00Z","timestamp":1648916940000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0078330"}},"subtitle":[],"editor":[{"given":"Paolo","family":"Madeddu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,10,21]]},"references-count":55,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,10,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0078330","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,21]]}}}